[Federal Register Volume 73, Number 237 (Tuesday, December 9, 2008)]
[Notices]
[Pages 74727-74728]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-29030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussion could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: February 6, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director of the National Center
for Complementary and Alternative Medicine, presentation of a new
research initiative, and other business of the Council.
Place: National Institutes of Health, Neuroscience Building,
6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD
20892.
[[Page 74728]]
Contact Person: Martin H. Goldrosen, PhD., Executive Secretary.
Director, Division of Extramural Activities. National Center for
Complementary and Alternative Medicine. National Institutes of
Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301)
594-2014.
The public comments session is scheduled from 3:30-4 p.m., but
could change depending on the actual time spent on each agenda item.
Each speaker will be permitted 5 minutes for their presentation.
Interested individuals and representatives of organizations are
requested to notify Dr. Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax: 301-480-9970.
Letters of intent to present comments, along with a brief description
of the organization represented, should be received no later than 5
p.m. on February 2, 2009. Only one representative of an organization
may present oral comments. Any person attending the meeting who does
not request an opportunity to speak in advance of the meeting may be
considered for oral presentation, if time permits, and at the
discretion of the Chairperson. In addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the address listed above up to
ten calendar days (February 16, 2009) following the meeting. Copies of
the meeting agenda and the roster of members will be furnished upon
request by contacting Dr. Martin H. Goldrosen, Executive Secretary,
NACCAM, National Center for Complementary and Alternative Medicine,
National Institutes of Health, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland 20892, 301-594-2014, Fax 301-480-9970, or via e-mail
at [email protected].
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government employees.
Persons without a government I.D. will need to show a photo I.D. and
sign in at the security desk upon entering the building.
Dated: December 2, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-29030 Filed 12-8-08; 8:45 am]
BILLING CODE 4140-01-P